Francisco J. Esteva: MRI surveillance significantly reduces breast cancer mortality in women with BRCA1 or BRCA2 mutation

Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital shared a post on LinkedIn:

“MRI surveillance significantly reduces breast cancer mortality in women with BRCA1 or BRCA2 mutations.

The reduction in new breast cancers and mortality is more evident in BRCA1 carriers. ”

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations

Authors: Jan Lubinski et al

For more information.

Source: Francisco J. Esteva/LinkedIn